Clinical Trial Update: A Study of THR-184 in Patients at Risk of Developing Cardiac Surgery Associated-Acute Kidney Injury (CSA-AKI) [Phase 2]

View source ↗

Summary

Phase 2 study update reporting results for THR-184 in patients at risk of cardiac surgery-associated acute kidney injury (CSA-AKI); the trial has completed and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• THR-184

Snippet

Sponsor: Thrasos Innovation, Inc. | Conditions: Acute Kidney Injury | Phase 2 | Status: COMPLETED | Results posted: 2017-04-20